Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darin T Okuda

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis and Related Disorders|October 22, 2023
Investigating the link between regional oxygen metabolism and cognitive speed in multiple sclerosis: Implications for fatigueMark D Zuppichini, Dinesh K Sivakolundu, Kathryn L West, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 15, 2023
MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody diseaseEdgar Carnero Contentti, Darin T Okuda, Juan I Rojas, et al.
Annals of Neurology|June 6, 2020
Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical EventChristine Lebrun-Frenay, Orhun Kantarci, Aksel Siva, et al.
Multiple Sclerosis and Related Disorders|October 7, 2023
Treatment transitions in neuromyelitis optica spectrum disorder increase risk for disease advancementDarin T Okuda, Tatum M Moog, Morgan McCreary, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of careDarin T Okuda, Katy W Burgess, Karin Cook, et al.
Neurology and Therapy|December 19, 2022
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple SclerosisCaroline Ruetsch-Chelli, Darin T Okuda, Fanny Rocher, et al.
The Lancet. Neurology|October 15, 2023
Radiologically isolated syndromeChristine Lebrun-Frenay, Orhun Kantarci, Aksel Siva, et al.
AJNR. American Journal of Neuroradiology|February 12, 2026
Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MSDarin T Okuda, Tom G Punnen, Tatum M Moog, et al.
Journal of Neurology|April 5, 2022
Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel diseaseTatum M Moog, Morgan McCreary, Andrew Wilson, et al.
Annals of Neurology|December 25, 2008
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to ironKathryn E Hammond, Meredith Metcalf, Lucas Carvajal, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis and Related Disorders|October 22, 2023
Investigating the link between regional oxygen metabolism and cognitive speed in multiple sclerosis: Implications for fatigueMark D Zuppichini, Dinesh K Sivakolundu, Kathryn L West, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 15, 2023
MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody diseaseEdgar Carnero Contentti, Darin T Okuda, Juan I Rojas, et al.
Annals of Neurology|June 6, 2020
Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical EventChristine Lebrun-Frenay, Orhun Kantarci, Aksel Siva, et al.
Multiple Sclerosis and Related Disorders|October 7, 2023
Treatment transitions in neuromyelitis optica spectrum disorder increase risk for disease advancementDarin T Okuda, Tatum M Moog, Morgan McCreary, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of careDarin T Okuda, Katy W Burgess, Karin Cook, et al.
Neurology and Therapy|December 19, 2022
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple SclerosisCaroline Ruetsch-Chelli, Darin T Okuda, Fanny Rocher, et al.
The Lancet. Neurology|October 15, 2023
Radiologically isolated syndromeChristine Lebrun-Frenay, Orhun Kantarci, Aksel Siva, et al.
AJNR. American Journal of Neuroradiology|February 12, 2026
Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MSDarin T Okuda, Tom G Punnen, Tatum M Moog, et al.
Journal of Neurology|April 5, 2022
Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel diseaseTatum M Moog, Morgan McCreary, Andrew Wilson, et al.
Annals of Neurology|December 25, 2008
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to ironKathryn E Hammond, Meredith Metcalf, Lucas Carvajal, et al.
Pageof 13